ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q2 2025 Earnings Conference Call August 12, 2025 4:30 PM ET
Company Participants
Joseph Michael Burnett – President, CEO & Director
Danilo D’Alessandro – Chief Financial Officer
Conference Call Participants
Frank James Takkinen – Lake Street Capital Markets, LLC, Research Division
Anderson Schock – B. Riley Securities, Inc., Research Division
Operator
Greetings, and welcome to the ClearPoint Neuro, Inc.’s Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Comments made on this call may include statements that are forward-looking within the meaning of securities laws. These forward-looking statements may include, without limitation, statements related to anticipated industry trends, the company’s plans, prospects and strategies, both preliminary and projected, the size of total addressable markets or the market opportunity for the company’s products and services, the company’s expectation for future development, regulatory approval and the market for cell and gene therapies and the anticipated adoption of the company’s products and services for use in the delivery of gene and cell therapies and management’s expectations, beliefs, estimates or projections regarding future revenue, results of operations or the adequacy of cash and cash equivalent balances to support operations and meet future obligations.
Actual results or trends could differ materially. The company undertakes no obligation to revise forward-looking statements for new information or future events. For more information, please refer to the company’s annual report on Form 10-K for the year ended December 31, 2024, and the company’s quarterly report on Form 10-Q for the 3 months ended March 31, 2025, both of which have been filed with the Securities and Exchange Commission, and the company’s quarterly report on Form 10-Q for the 3 months ended June 30, 2025, which the company intends to file with the Securities and Exchange Commission on or before August 14, 2025. All the company’s filings may be obtained
#ClearPoint #Neuro #CLPT #Earnings #Call #Transcript